Milgusto 4 mg/10 mg chewable tablets for small cats and kittens weighing at least 0.5 kg

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

מרכיב פעיל:

Milbemycin oxime; Praziquantel

זמין מ:

Krka, d.d., Novo mesto

קוד ATC:

QP54AB51

INN (שם בינלאומי):

Milbemycin oxime; Praziquantel

כמות:

4, 10 mg/tablet

טופס פרצבטיות:

Chewable tablet

סוג מרשם:

POM: Prescription Only Medicine as defined in relevant national legislation

איזור תרפויטי:

milbemycin oxime, combinations

מצב אישור:

Authorised

תאריך אישור:

2018-07-27

מאפייני מוצר

Health Products Regulatory Authority
15 July 2021
CRN00C9QC
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Milgusto 4 mg/10 mg chewable tablets for small cats and kittens
weighing at least 0.5 kg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains:
ACTIVE SUBSTANCES:
​
​
Milbemycin oxime
4
mg
Praziquantel
10
mg
​
​
​
EXCIPIENTS:
​
​
Iron Oxide, yellow (E172)
0.18
mg
​
Iron Oxide, red (E172)
​
0.02
​
mg
Titanium dioxide (E171)
0.21
mg
For the full list of excipients, see section 6.1.
​
​
3 PHARMACEUTICAL FORM
Film-coated tablet.
Brownish orange, oval, biconvex film-coated tablets with score line on
one side.
The tablets can be divided into halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats (small cats and kittens).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by immature and adult cestodes and
nematodes of the following species:
- Cestodes:
_Dipylidium caninum_
_Taenia _spp.
_Echinococcus multilocularis_
_ _
- Nematodes:
_Ancylostoma tubaeforme_
_Toxocara cati_
Prevention of heartworm disease (_Dirofilaria immitis_) if concomitant
treatment against cestodes is indicated.
4.3 CONTRAINDICATIONS
Do not use in cats of less than 6 weeks of age and/or weighing less
than 0.5 kg.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
It is recommended to treat all the animals living in the same
household concomitantly.
In order to develop an effective worm control programme local
epidemiological information and the risk of exposure of the cat
should be taken into account, and it is recommended to seek
professional (e. g. veterinary) advice.
When _D. caninum_ infection is present, concomitant treatment against
intermediate hosts, such as fleas and lice, should be
considered to prevent re-infection.
Health Products Regulatory Authority
15 July 2021
CRN00C9QC
Page 2 of 5
Parasite resistance to any particular c